Kamban Hirasen to Anti-HIV Agents
This is a "connection" page, showing publications Kamban Hirasen has written about Anti-HIV Agents.
Connection Strength
0,465
-
Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa: a retrospective cohort study. Lancet HIV. 2025 Feb; 12(2):e130-e142.
Score: 0,125
-
One Pill, Once a Day: Simplified Treatment Regimens and Retention in HIV Care. Am J Epidemiol. 2022 May 20; 191(6):999-1008.
Score: 0,104
-
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa. Drug Saf. 2018 12; 41(12):1343-1353.
Score: 0,082
-
Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa. PLoS One. 2018; 13(9):e0203797.
Score: 0,081
-
Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa. AIDS Patient Care STDS. 2017 May; 31(5):205-212.
Score: 0,073